インデックス付き
- Jゲートを開く
- ジャーナル目次
- グローバル インパクト ファクター (GIF)
- レフシーク
- ハムダード大学
- エブスコ アリゾナ州
- OCLC-WorldCat
- パブロン
- ユーロパブ
- Google スカラー
このページをシェアする
ジャーナルチラシ
概要
Pharmacovigilance in India and Its Challenges
Puneet Boora, Patil Rohilla Kumar, Patil Harish Chandra
The thalidomide disaster is a turning phase in the expansion of Pharmacovigilance (PV) worldwide. Pharmacovigilance is very critical to the healthcare system for the safe treatment of an individual. Drugs are designed to cure, prevent or for treatment, alongside drugs can also cause harm to the patient in terms of ADR (Adverse Drug Reaction). PV should be an integral part of the healthcare system, especially in countries like India, where there are over one billion drug consumers, however until now pharmacovigilance is a new concept in many developing countries. This article provides a complete overview of pharmacovigilance and pharmacovigilance programs that are doing outstanding jobs in India to eradicate the ADR of drugs. It will also highlight the journey of pharmacovigilance in India.